• Interview: The future of gastrointestinal oncology

    This interview after the 'ESMO GI Cancers 2024' congress was an opportunity for in-depth study and discussion of new developments in GI oncology.

  • Treating GI tumours in geriatric patients

    Gastrointestinal tumours occur most frequently in people over 70. But how does the treatment of geriatric patients differ from that of younger patients?

  • Gynaecological oncology: present and future

    During the ESMO Congress on Gynaecological Cancers, Prof. Scambia analysed developments in the field, and what's next in the coming decade.

  • Colon carcinoma: current biomarker tools and new developments

    Precision medicine is revolutionising treatments for colon cancer and other gastrointestinal malignancies by identifying biomarkers for personalised therapies.

  • New targets in immunotherapy

    New immunotherapies go beyond CTLA-4 and PD(L)1 and show promising results for treating various types of cancer, including colorectal cancer.

  • ESMO Congress

    None